Related Experiment Video
Updated: Feb 14, 2026

Isolation of the Side Population in Myc-induced T-cell Acute Lymphoblastic Leukemia in Zebrafish
Published on: May 4, 2017
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Na Zhao1,2,3, Jin Cao1,2,3, Longyong Xu1,2,3
1Department of Molecular and Cellular Biology.
Abstract:
The unfolded protein response (UPR) is a cellular homeostatic mechanism that is activated in many human cancers and plays pivotal roles in tumor progression and therapy resistance. However, the molecular mechanisms for UPR activation and regulation in cancer cells remain elusive. Here, we show that oncogenic MYC regulates the inositol-requiring enzyme 1 (IRE1)/X-box binding protein 1 (XBP1) branch of the UPR in breast cancer via multiple mechanisms. We found that MYC directly controls IRE1 transcription by binding to its promoter and enhancer. Furthermore, MYC forms a transcriptional complex with XBP1, a target of IRE1, and enhances its transcriptional activity. Importantly, we demonstrate that XBP1 is a synthetic lethal partner of MYC. Silencing of XBP1 selectively blocked the growth of MYC-hyperactivated cells. Pharmacological inhibition of IRE1 RNase activity with small molecule inhibitor 8866 selectively restrained the MYC-overexpressing tumor growth in vivo in a cohort of preclinical patient-derived xenograft models and genetically engineered mouse models. Strikingly, 8866 substantially enhanced the efficacy of docetaxel chemotherapy, resulting in rapid regression of MYC-overexpressing tumors. Collectively, these data establish the synthetic lethal interaction of the IRE1/XBP1 pathway with MYC hyperactivation and provide a potential therapy for MYC-driven human breast cancers.
Insights
Oncogenic MYC drives breast cancer by activating the unfolded protein response (UPR) via the IRE1/XBP1 pathway. Inhibiting this pathway selectively kills MYC-driven cancer cells and enhances chemotherapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Homeostasis
Background:
- The unfolded protein response (UPR) is crucial in cancer, influencing tumor progression and treatment resistance.
- Mechanisms of UPR activation and regulation in cancer remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which oncogenic MYC regulates the IRE1/XBP1 branch of the UPR in breast cancer.
- To investigate the therapeutic potential of targeting the IRE1/XBP1 pathway in MYC-driven cancers.
Main Methods:
- Investigated MYC's regulation of IRE1 transcription via promoter and enhancer binding.
- Analyzed MYC-XBP1 transcriptional complex formation and activity.
- Assessed the synthetic lethality of XBP1 silencing in MYC-hyperactivated cells.
- Evaluated the efficacy of IRE1 RNase inhibitor 8866 in preclinical cancer models and in combination with docetaxel.
Main Results:
- MYC directly controls IRE1 transcription and enhances XBP1 transcriptional activity.
- XBP1 acts as a synthetic lethal partner to MYC; its silencing selectively inhibits MYC-hyperactivated cell growth.
- Pharmacological inhibition of IRE1 RNase activity with 8866 suppressed MYC-overexpressing tumor growth in vivo.
- 8866 significantly potentiated docetaxel efficacy, leading to rapid tumor regression.
Conclusions:
- Established a synthetic lethal interaction between the IRE1/XBP1 pathway and MYC hyperactivation.
- Demonstrated that targeting the IRE1/XBP1 pathway is a promising therapeutic strategy for MYC-driven breast cancers.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
GTPases and their Regulation
Large G-proteins,...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

